{"id":334640,"date":"2026-11-02T11:13:51","date_gmt":"2026-11-02T05:43:51","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=334640"},"modified":"2026-11-02T11:13:51","modified_gmt":"2026-11-02T05:43:51","slug":"largecap-quarterly-profit-growth-and-high-margin-stocks-to-watch-multibagger-potential","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/largecap-quarterly-profit-growth-and-high-margin-stocks-to-watch-multibagger-potential\/","title":{"rendered":"4 Largecap Quarterly Profit Growth and High Margin Stocks to Watch for Future Multibagger Potential: Sun Pharma, Divi&#8217;s Labs, Eicher Motors and Indian Hotels"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Sun Pharma Rs 1,777.70. Divi&#8217;s Labs Rs 9,780. Eicher Motors Rs 7,220. Indian Hotels Rs 811.65. Market caps from Rs 1.12 lakh crore to Rs 4.27 lakh crore. Data as of 30 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Sun Pharma, Divi&#8217;s Labs, Eicher Motors and Indian Hotels are the 4 picks in this quarterly profit growth and high margin stocks watchlist, with market caps between Rs 1.12 lakh crore and Rs 4.27 lakh crore. Sun Pharma stands out for the fastest profit growth, 35.75% a year since FY22, while Divi&#8217;s Labs offers the strongest latest-quarter profit growth at 65.50%. PE ratios run from 34.26 to 87.58, so compare each one with its industry PE before investing. All figures are as of 30 October 2026.<\/p>\n<\/p><\/div>\n<p>Quarterly profit growth and high margin stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Sun Pharma, Divi&#8217;s Labs, Eicher Motors and Indian Hotels meet that test, with market caps from Rs 1.12 lakh crore to Rs 4.27 lakh crore and Sun Pharma offering the fastest profit growth, 35.75% a year since FY22. Each of these companies has latest quarter net profit growth of at least 20 per cent year on year and an operating margin of at least 20 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.<\/p>\n<p>This list covers companies with latest quarter net profit growth of at least 20 per cent year on year and an operating margin of at least 20 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening quarterly profit growth and high margin stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 30 October 2026 and are drawn from NSE and BSE data and company filings.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=quarterly-profit-growth-and-high-margin-stocks\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/largecap-quarterly-profit-growth-and-high-margin-stocks-to-watch-multibagger-potential\/#What_Are_Quarterly_Profit_Growth_and_High_Margin_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\" title=\"What Are Quarterly Profit Growth and High Margin Stocks and Why Do They Attract Multibagger Interest?\">What Are Quarterly Profit Growth and High Margin Stocks and Why Do They Attract Multibagger Interest?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/largecap-quarterly-profit-growth-and-high-margin-stocks-to-watch-multibagger-potential\/#Quarterly_Profit_Growth_and_High_Margin_Stocks_at_a_Glance_Price_Market_Cap_PE_and_ROE\" title=\"Quarterly Profit Growth and High Margin Stocks at a Glance: Price, Market Cap, PE and ROE\">Quarterly Profit Growth and High Margin Stocks at a Glance: Price, Market Cap, PE and ROE<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/largecap-quarterly-profit-growth-and-high-margin-stocks-to-watch-multibagger-potential\/#Sun_Pharma_3575_Profit_CAGR_Since_FY22\" title=\"Sun Pharma: 35.75% Profit CAGR Since FY22\">Sun Pharma: 35.75% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/largecap-quarterly-profit-growth-and-high-margin-stocks-to-watch-multibagger-potential\/#Divis_Labs_Debt-to-Equity_of_000\" title=\"Divi&#8217;s Labs: Debt-to-Equity of 0.00\">Divi&#8217;s Labs: Debt-to-Equity of 0.00<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/largecap-quarterly-profit-growth-and-high-margin-stocks-to-watch-multibagger-potential\/#Eicher_Motors_3467_Profit_CAGR_Since_FY22\" title=\"Eicher Motors: 34.67% Profit CAGR Since FY22\">Eicher Motors: 34.67% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/largecap-quarterly-profit-growth-and-high-margin-stocks-to-watch-multibagger-potential\/#Indian_Hotels_Quarterly_Profit_Up_2239\" title=\"Indian Hotels: Quarterly Profit Up 22.39%\">Indian Hotels: Quarterly Profit Up 22.39%<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/largecap-quarterly-profit-growth-and-high-margin-stocks-to-watch-multibagger-potential\/#Quarterly_Profit_Growth_and_High_Margin_Stocks_Financial_Comparison_on_Growth_and_Margins\" title=\"Quarterly Profit Growth and High Margin Stocks: Financial Comparison on Growth and Margins\">Quarterly Profit Growth and High Margin Stocks: Financial Comparison on Growth and Margins<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/largecap-quarterly-profit-growth-and-high-margin-stocks-to-watch-multibagger-potential\/#Institutional_Holding_in_Sun_Pharma_Divis_Labs_Eicher_Motors_and_Indian_Hotels\" title=\"Institutional Holding in Sun Pharma, Divi&#8217;s Labs, Eicher Motors and Indian Hotels\">Institutional Holding in Sun Pharma, Divi&#8217;s Labs, Eicher Motors and Indian Hotels<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/largecap-quarterly-profit-growth-and-high-margin-stocks-to-watch-multibagger-potential\/#Risks_to_Weigh_in_Quarterly_Profit_Growth_and_High_Margin_Stocks\" title=\"Risks to Weigh in Quarterly Profit Growth and High Margin Stocks\">Risks to Weigh in Quarterly Profit Growth and High Margin Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/largecap-quarterly-profit-growth-and-high-margin-stocks-to-watch-multibagger-potential\/#How_to_Choose_Between_Quarterly_Profit_Growth_and_High_Margin_Stocks\" title=\"How to Choose Between Quarterly Profit Growth and High Margin Stocks\">How to Choose Between Quarterly Profit Growth and High Margin Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/largecap-quarterly-profit-growth-and-high-margin-stocks-to-watch-multibagger-potential\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/largecap-quarterly-profit-growth-and-high-margin-stocks-to-watch-multibagger-potential\/#Frequently_Asked_Questions_on_Quarterly_Profit_Growth_and_High_Margin_Stocks_to_Watch\" title=\"Frequently Asked Questions on Quarterly Profit Growth and High Margin Stocks to Watch\">Frequently Asked Questions on Quarterly Profit Growth and High Margin Stocks to Watch<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/largecap-quarterly-profit-growth-and-high-margin-stocks-to-watch-multibagger-potential\/#Which_are_the_best_quarterly_profit_growth_and_high_margin_stocks_to_watch_for_multibagger_potential\" title=\"Which are the best quarterly profit growth and high margin stocks to watch for multibagger potential?\">Which are the best quarterly profit growth and high margin stocks to watch for multibagger potential?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/largecap-quarterly-profit-growth-and-high-margin-stocks-to-watch-multibagger-potential\/#Is_Eicher_Motors_a_good_stock_for_long-term_investors\" title=\"Is Eicher Motors a good stock for long-term investors?\">Is Eicher Motors a good stock for long-term investors?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/largecap-quarterly-profit-growth-and-high-margin-stocks-to-watch-multibagger-potential\/#Can_Sun_Pharma_become_a_multibagger_from_here\" title=\"Can Sun Pharma become a multibagger from here?\">Can Sun Pharma become a multibagger from here?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/largecap-quarterly-profit-growth-and-high-margin-stocks-to-watch-multibagger-potential\/#What_is_the_market_cap_of_Sun_Pharma_Divis_Labs_Eicher_Motors_and_Indian_Hotels\" title=\"What is the market cap of Sun Pharma, Divi&#8217;s Labs, Eicher Motors and Indian Hotels?\">What is the market cap of Sun Pharma, Divi&#8217;s Labs, Eicher Motors and Indian Hotels?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/largecap-quarterly-profit-growth-and-high-margin-stocks-to-watch-multibagger-potential\/#What_are_the_risks_of_investing_in_quarterly_profit_growth_and_high_margin_stocks\" title=\"What are the risks of investing in quarterly profit growth and high margin stocks?\">What are the risks of investing in quarterly profit growth and high margin stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/largecap-quarterly-profit-growth-and-high-margin-stocks-to-watch-multibagger-potential\/#Why_is_Divis_Labs_trading_at_a_PE_of_8758\" title=\"Why is Divi&#8217;s Labs trading at a PE of 87.58?\">Why is Divi&#8217;s Labs trading at a PE of 87.58?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/largecap-quarterly-profit-growth-and-high-margin-stocks-to-watch-multibagger-potential\/#How_much_do_institutions_hold_in_Sun_Pharma_Divis_Labs_Eicher_Motors_and_Indian_Hotels\" title=\"How much do institutions hold in Sun Pharma, Divi&#8217;s Labs, Eicher Motors and Indian Hotels?\">How much do institutions hold in Sun Pharma, Divi&#8217;s Labs, Eicher Motors and Indian Hotels?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Quarterly_Profit_Growth_and_High_Margin_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\"><\/span><strong>What Are Quarterly Profit Growth and High Margin Stocks and Why Do They Attract Multibagger Interest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Quarterly profit growth and high margin stocks are shares of large companies whose profit grew by twenty per cent or more in the latest quarter and which keep at least twenty paise of operating profit from every rupee of sales. The four here cover pharmaceuticals, pharmaceutical ingredients, premium motorcycles and hotels.<\/p>\n<p>Fast profit growth in the latest quarter shows current momentum, and a high operating margin shows that the growth rests on pricing power and cost control and not on discounts. Within quarterly profit growth and high margin stocks, the four companies show rising profit. For quarterly profit growth and high margin stocks, both FY26 and the latest quarter showed growth. Whichever way you read quarterly profit growth and high margin stocks, the common thread is rising profit backed by complete financial data. Investors researching quarterly profit growth and high margin stocks get a fuller picture by reading growth and valuation together. The table below lines up quarterly profit growth and high margin stocks on size, growth and valuation, using complete FY26 and latest quarter numbers. Past performance does not guarantee future returns, so use quarterly profit growth and high margin stocks as a starting point for your own research.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Quarterly_Profit_Growth_and_High_Margin_Stocks_at_a_Glance_Price_Market_Cap_PE_and_ROE\"><\/span><strong>Quarterly Profit Growth and High Margin Stocks at a Glance: Price, Market Cap, PE and ROE<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Prices are closing prices as of 30 October 2026. Eicher Motors combines the lowest PE of the group, 34.26, with the highest return on equity, 21.97%.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Industry PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Debt to Equity<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">52-Week Range (Rs)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\">Sun Pharmaceutical Industries<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,777.70<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4,27,161<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">35.25<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36.42<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.74%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.06<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,583.70 to 2,046.90<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi's-laboratories-ltd-share-price-today\">Divi&#8217;s Laboratories<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9,780<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,56,169<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">87.58<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36.42<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.32%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.00<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5,647.50 to 9,780.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/eichermot\/eicher-motors-ltd-share-price-today\">Eicher Motors<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7,220<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,97,802<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">34.26<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.82<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">21.97%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.02<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">6,442.00 to 8,230.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/indhotel\/the-indian-hotels-company-ltd-share-price-today\">Indian Hotels Company<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">811.65<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,12,493<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">48.72<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36.77<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.97%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.22<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">568.70 to 971.00<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Sun_Pharma_3575_Profit_CAGR_Since_FY22\"><\/span><strong>Sun Pharma: 35.75% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Sun Pharmaceutical Industries is one of India&#8217;s largest drugmakers and sells generic and specialty medicines in India and overseas. It reported FY26 revenue of Rs 61,673.94 crore, up 12.69% year on year, and net profit of Rs 11,564.52 crore, up 5.32%. Net profit has compounded at 35.75% a year since FY22, while revenue has grown 11.62% a year. Operating margin was 31.47% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.<\/p>\n<p>In the June 2026 quarter, revenue rose 11.93% to Rs 16,023.50 crore and net profit grew 26.41% to Rs 2,910.80 crore. The share price has gained 110.81% over five years. Domestic institutions raised their holding from 20.23% in September 2025 to 22.27% in September 2026. The stock trades at a PE of 35.25 against an industry PE of 36.42, below the sector average, with a return on equity of 13.74%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Divis_Labs_Debt-to-Equity_of_000\"><\/span><strong>Divi&#8217;s Labs: Debt-to-Equity of 0.00<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Divi&#8217;s Laboratories makes active pharmaceutical ingredients and intermediates and runs a large custom synthesis business for global drug companies. It reported FY26 revenue of Rs 11,067 crore, up 13.95% year on year, and net profit of Rs 2,568 crore, up 17.21%. Revenue has compounded at 5.09% a year since FY22. Operating margin was 36.70% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.<\/p>\n<p>The stock trades at a PE of 87.58 against an industry PE of 36.42, with a return on equity of 15.32%. In the June 2026 quarter, revenue rose 24.32% to Rs 3,144 crore and net profit grew 65.50% to Rs 902 crore. The share price has gained 71.04% over five years and 38.43% over the past year. Foreign investors raised their holding from 19.39% in September 2025 to 20.38% in September 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Eicher_Motors_3467_Profit_CAGR_Since_FY22\"><\/span><strong>Eicher Motors: 34.67% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Eicher Motors owns the Royal Enfield brand of premium motorcycles and is a partner in the Eicher commercial vehicle business. It reported FY26 revenue of Rs 24,894.09 crore, up 23.39% year on year, and net profit of Rs 5,515.23 crore, up 16.49%. Net profit has compounded at 34.67% a year since FY22, while revenue has grown 23.39% a year. Operating margin was 34.24% in FY26. The debt-to-equity ratio is 0.02, which keeps interest costs low.<\/p>\n<p>In the June 2026 quarter, revenue rose 29.35% to Rs 7,098.73 crore and net profit grew 21.35% to Rs 1,462.51 crore. The share price has gained 174.76% over five years. The stock trades at a PE of 34.26 against an industry PE of 23.82, with a return on equity of 21.97%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Indian_Hotels_Quarterly_Profit_Up_2239\"><\/span><strong>Indian Hotels: Quarterly Profit Up 22.39%<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Indian Hotels Company, part of the Tata Group, runs Taj, SeleQtions, Vivanta and Ginger hotels and resorts. It reported FY26 revenue of Rs 9,971.43 crore, up 16.42% year on year, and net profit of Rs 2,195.14 crore, up 11.93%. Revenue has compounded at 32.74% a year since FY22. Operating margin was 35.53% in FY26. The debt-to-equity ratio is 0.22.<\/p>\n<p>The stock trades at a PE of 48.72 against an industry PE of 36.77, with a return on equity of 15.97%. In the June 2026 quarter, revenue rose 15.09% to Rs 2,419.37 crore and net profit grew 22.39% to Rs 390.93 crore. The share price has gained 658.38% over five years. Domestic institutions raised their holding from 18.52% in June 2025 to 24.59% in June 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Quarterly_Profit_Growth_and_High_Margin_Stocks_Financial_Comparison_on_Growth_and_Margins\"><\/span><strong>Quarterly Profit Growth and High Margin Stocks: Financial Comparison on Growth and Margins<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares scale and growth across these quarterly profit growth and high margin stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue Growth (YoY)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Revenue CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Latest Quarter Revenue Growth<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Operating Margin (Latest Quarter)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Sun Pharma<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">61,673.94<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11,564.52<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.69%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.62%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.93%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">32.52%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Divi&#8217;s Labs<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11,067<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,568<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.95%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5.09%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">24.32%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">42.82%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Eicher Motors<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">24,894.09<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5,515.23<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.39%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.39%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">29.35%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">34.28%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Indian Hotels<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9,971.43<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,195.14<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.42%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">32.74%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.09%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">32.19%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these quarterly profit growth and high margin stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Institutional_Holding_in_Sun_Pharma_Divis_Labs_Eicher_Motors_and_Indian_Hotels\"><\/span><strong>Institutional Holding in Sun Pharma, Divi&#8217;s Labs, Eicher Motors and Indian Hotels<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Institutional holding shows who is backing these quarterly profit growth and high margin stocks alongside the promoter. The table uses the latest reported quarter for each. Indian Hotels has the deepest institutional backing, with FII and DII together holding 46.30% as of June 2026. Domestic institutions increased their holding over the past year in Sun Pharma (from 20.23% to 22.27%) and Indian Hotels (from 18.52% to 24.59%).<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Promoter<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">FII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">DII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Public<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Quarter<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Sun Pharma<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">52.68%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">14.36%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">22.27%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.70%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Divi&#8217;s Labs<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">51.88%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.38%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">19.17%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">8.58%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Eicher Motors<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">49.02%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">25.53%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.06%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9.40%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Indian Hotels<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">38.12%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">21.71%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">24.59%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.58%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Weigh_in_Quarterly_Profit_Growth_and_High_Margin_Stocks\"><\/span><strong>Risks to Weigh in Quarterly Profit Growth and High Margin Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Being careful with quarterly profit growth and high margin stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:<\/p>\n<ul>\n<li>Past growth may not repeat.<\/li>\n<li>Share prices can move sharply in either direction.<\/li>\n<li><strong>Valuation:<\/strong> Divi&#8217;s Labs trades at a PE of 87.58 against an industry PE of 36.42, so earnings need to keep growing to support the price.<\/li>\n<li><strong>Concentration:<\/strong> Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Choose_Between_Quarterly_Profit_Growth_and_High_Margin_Stocks\"><\/span><strong>How to Choose Between Quarterly Profit Growth and High Margin Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Picking from quarterly profit growth and high margin stocks comes down to four checks, applied in order.<\/p>\n<ol>\n<li>Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.<\/li>\n<li>Compare each PE with the industry PE (23.82 to 36.77) and ask whether the growth rate justifies any gap.<\/li>\n<li>Track net profit growth, the operating margin and the return on equity in every quarterly result.<\/li>\n<li>Stagger entries across quarters and review institutional holding every reporting season.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Sun Pharma, Divi&#8217;s Labs, Eicher Motors and Indian Hotels live prices.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among quarterly profit growth and high margin stocks, Sun Pharma stands out for the fastest profit growth, 35.75% a year since FY22, Divi&#8217;s Labs for the strongest latest-quarter profit growth at 65.50%, Eicher Motors for the highest return on equity at 21.97% and Indian Hotels for the biggest five-year price gain at 658.38%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing quarterly profit growth and high margin stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Quarterly_Profit_Growth_and_High_Margin_Stocks_to_Watch\"><\/span><strong>Frequently Asked Questions on Quarterly Profit Growth and High Margin Stocks to Watch<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_quarterly_profit_growth_and_high_margin_stocks_to_watch_for_multibagger_potential\"><\/span><strong>Which are the best quarterly profit growth and high margin stocks to watch for multibagger potential?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sun Pharma, Divi&#8217;s Labs, Eicher Motors and Indian Hotels are the 4 names this list highlights, with market caps of Rs 4,27,161 crore, Rs 2,56,169 crore, Rs 1,97,802 crore and Rs 1,12,493 crore respectively. Sun Pharma is notable for the fastest profit growth, 35.75% a year since FY22. Divi&#8217;s Labs stands out for the strongest latest-quarter profit growth at 65.50%. Eicher Motors offers the highest return on equity at 21.97%. Indian Hotels brings the biggest five-year price gain at 658.38%. These are watchlist names for quarterly profit growth and high margin stocks, not recommendations, so match each one to your own risk profile and time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Eicher_Motors_a_good_stock_for_long-term_investors\"><\/span><strong>Is Eicher Motors a good stock for long-term investors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Eicher Motors has a return on equity of 21.97%, a PE of 34.26 against an industry PE of 23.82 and a market cap of Rs 1,97,802 crore. Net profit has compounded at 34.67% a year since FY22, and FY26 revenue rose 23.39% while June 2026 quarter net profit grew 21.35%. Long-term returns in quarterly profit growth and high margin stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_Sun_Pharma_become_a_multibagger_from_here\"><\/span><strong>Can Sun Pharma become a multibagger from here?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sun Pharma has already gained 110.81% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in quarterly profit growth and high margin stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 35.25 against an industry PE of 36.42, valuation should be checked against that growth before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_Sun_Pharma_Divis_Labs_Eicher_Motors_and_Indian_Hotels\"><\/span><strong>What is the market cap of Sun Pharma, Divi&#8217;s Labs, Eicher Motors and Indian Hotels?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of 30 October 2026, Sun Pharma has a market cap of Rs 4,27,161 crore, Divi&#8217;s Labs has a market cap of Rs 2,56,169 crore, Eicher Motors has a market cap of Rs 1,97,802 crore and Indian Hotels has a market cap of Rs 1,12,493 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on quarterly profit growth and high margin stocks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_quarterly_profit_growth_and_high_margin_stocks\"><\/span><strong>What are the risks of investing in quarterly profit growth and high margin stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Divi&#8217;s Labs trades at a PE of 87.58 against an industry PE of 36.42, so earnings growth needs to hold up.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Divis_Labs_trading_at_a_PE_of_8758\"><\/span><strong>Why is Divi&#8217;s Labs trading at a PE of 87.58?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Divi&#8217;s Labs&#8217; PE of 87.58 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 15.32% and latest-quarter profit growth of 65.50%, which also means the stock is more sensitive if growth slows. Investors in quarterly profit growth and high margin stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_do_institutions_hold_in_Sun_Pharma_Divis_Labs_Eicher_Motors_and_Indian_Hotels\"><\/span><strong>How much do institutions hold in Sun Pharma, Divi&#8217;s Labs, Eicher Motors and Indian Hotels?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of the latest reported quarter, FII and DII together hold 36.63% of Sun Pharma (14.36% and 22.27%), 39.55% of Divi&#8217;s Labs (20.38% and 19.17%), 41.59% of Eicher Motors (25.53% and 16.06%) and 46.30% of Indian Hotels (21.71% and 24.59%). Rising institutional holding is a useful signal in quarterly profit growth and high margin stocks, though it should be read with earnings trends rather than on its own.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best quarterly profit growth and high margin stocks to watch for multibagger potential?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Sun Pharma, Divi's Labs, Eicher Motors and Indian Hotels are the 4 names this list highlights, with market caps of Rs 4,27,161 crore, Rs 2,56,169 crore, Rs 1,97,802 crore and Rs 1,12,493 crore respectively. Sun Pharma is notable for the fastest profit growth, 35.75% a year since FY22. Divi's Labs stands out for the strongest latest-quarter profit growth at 65.50%. Eicher Motors offers the highest return on equity at 21.97%. Indian Hotels brings the biggest five-year price gain at 658.38%. These are watchlist names for quarterly profit growth and high margin stocks, not recommendations, so match each one to your own risk profile and time horizon.\"}},{\"@type\":\"Question\",\"name\":\"Is Eicher Motors a good stock for long-term investors?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Eicher Motors has a return on equity of 21.97%, a PE of 34.26 against an industry PE of 23.82 and a market cap of Rs 1,97,802 crore. Net profit has compounded at 34.67% a year since FY22, and FY26 revenue rose 23.39% while June 2026 quarter net profit grew 21.35%. Long-term returns in quarterly profit growth and high margin stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.\"}},{\"@type\":\"Question\",\"name\":\"Can Sun Pharma become a multibagger from here?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Sun Pharma has already gained 110.81% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in quarterly profit growth and high margin stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 35.25 against an industry PE of 36.42, valuation should be checked against that growth before investing.\"}},{\"@type\":\"Question\",\"name\":\"What is the market cap of Sun Pharma, Divi's Labs, Eicher Motors and Indian Hotels?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of 30 October 2026, Sun Pharma has a market cap of Rs 4,27,161 crore, Divi's Labs has a market cap of Rs 2,56,169 crore, Eicher Motors has a market cap of Rs 1,97,802 crore and Indian Hotels has a market cap of Rs 1,12,493 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on quarterly profit growth and high margin stocks.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in quarterly profit growth and high margin stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Divi's Labs trades at a PE of 87.58 against an industry PE of 36.42, so earnings growth needs to hold up.\"}},{\"@type\":\"Question\",\"name\":\"Why is Divi's Labs trading at a PE of 87.58?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Divi's Labs' PE of 87.58 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 15.32% and latest-quarter profit growth of 65.50%, which also means the stock is more sensitive if growth slows. Investors in quarterly profit growth and high margin stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.\"}},{\"@type\":\"Question\",\"name\":\"How much do institutions hold in Sun Pharma, Divi's Labs, Eicher Motors and Indian Hotels?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of the latest reported quarter, FII and DII together hold 36.63% of Sun Pharma (14.36% and 22.27%), 39.55% of Divi's Labs (20.38% and 19.17%), 41.59% of Eicher Motors (25.53% and 16.06%) and 46.30% of Indian Hotels (21.71% and 24.59%). Rising institutional holding is a useful signal in quarterly profit growth and high margin stocks, though it should be read with earnings trends rather than on its own.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>4 largecap quarterly profit growth and high margin stocks compared on market cap, PE, ROE, growth and institutional holding: Sun Pharma, Divi&#8217;s Labs, Eicher Motors and Indian Hotels.<\/p>\n","protected":false},"author":33,"featured_media":334639,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[18945,18944],"class_list":["post-334640","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-quarterly-profit-growth-and-high-margin-sector","tag-quarterly-profit-growth-and-high-margin-stocks"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["334639"],"rank_math_title":["Quarterly Profit Growth and High Margin Stocks to Watch in 2026"],"rank_math_description":["Quarterly profit growth and high margin stocks to watch for multibagger potential: Sun Pharma, Divi's Labs, Eicher Motors and Indian Hotels. Compare PE, ROE and growth."],"rank_math_focus_keyword":["quarterly profit growth and high margin stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/4-largecap-quarterly-profit-growth-and-high-margin-stocks-to-watch-for-future.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/334640","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=334640"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/334640\/revisions"}],"predecessor-version":[{"id":334642,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/334640\/revisions\/334642"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/334639"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=334640"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=334640"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=334640"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}